» Authors » Melanie Trivett

Melanie Trivett

Explore the profile of Melanie Trivett including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 10
Citations 398
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Gardiner F, Schofield Z, Hendry M, Jones K, Smallacombe M, Steere M, et al.
Front Public Health . 2023 Aug; 11:1019536. PMID: 37529430
Background: The Royal Flying Doctor Service of Australia (RFDS) established a unique SARS-CoV-2 vaccination program for vaccinating Australians that live in rural and remote areas. This paper describes the preparation...
2.
Huynh D, Dai X, Nandi S, Lightowler S, Trivett M, Chan C, et al.
Gastroenterology . 2009 Mar; 137(1):136-44, 144.e1-3. PMID: 19303020
Background & Aims: Paneth cells (PCs) secrete defensins and antimicrobial enzymes that contribute to innate immunity against pathogen infections within the mucosa of the small intestine. We examined the role...
3.
Westwood J, Murray W, Trivett M, Haynes N, Solomon B, Mileshkin L, et al.
J Immunother . 2009 Feb; 32(3):292-301. PMID: 19242371
In this study we aimed to determine the suitability of the Lewis-Y carbohydrate antigen as a target for immunotherapy using genetically redirected T cells. Using the 3S193 monoclonal antibody and...
4.
Liu W, McArthur G, Trivett M, Murray W, Wolfe R, Kelly J
Arch Dermatol . 2008 Apr; 144(4):555-6. PMID: 18427059
No abstract available.
5.
Qiu W, Hu M, Sridhar A, Opeskin K, Fox S, Shipitsin M, et al.
Nat Genet . 2008 Apr; 40(5):650-5. PMID: 18408720
There is increasing evidence showing that the stromal cells surrounding cancer epithelial cells, rather than being passive bystanders, might have a role in modifying tumor outgrowth. The molecular basis of...
6.
Mileshkin L, Honemann D, Gambell P, Trivett M, Hayakawa Y, Smyth M, et al.
Haematologica . 2007 Jul; 92(8):1075-82. PMID: 17640854
Background And Objectives: In vitro studies suggest that thalidomide has an immunoregulatory role and alters the marrow microenvironment. We assessed laboratory and clinical parameters in patients with myeloma treated with...
7.
Liu W, Kelly J, Trivett M, Murray W, Dowling J, Wolfe R, et al.
J Invest Dermatol . 2006 Dec; 127(4):900-5. PMID: 17159915
The BRAF(T1799A) mutation encodes BRAF(V600E) that leads to activation of the mitogen-activated protein kinase pathway. This study aimed to assess the clinico-pathological features of primary invasive melanomas containing the BRAF(T1799A)...
8.
Southey M, Jenkins M, Mead L, Whitty J, Trivett M, Tesoriero A, et al.
J Clin Oncol . 2005 Aug; 23(27):6524-32. PMID: 16116158
Purpose: The relationships between mismatch repair (MMR) protein expression, microsatellite instability (MSI), family history, and germline MMR gene mutation status have not been studied on a population basis. Methods: We...
9.
Wei A, Westerman D, Feleppa F, Trivett M, Juneja S
Haematologica . 2005 Aug; 90(8):1147-9. PMID: 16079123
Plasma cell microaggregates detected by CD138 immunohistology were demonstrated in 22% of patients achieving morphologic remission 3 months after high-dose therapy for myeloma. Microaggregates were predictive of earlier disease progression,...
10.
Loughrey M, Trivett M, Lade S, Murray W, Turner H, Waring P
Pathology . 2004 Sep; 36(4):301-8. PMID: 15370127
Aims: Epstein-Barr virus (EBV) has been implicated in the pathogenesis of nasopharyngeal carcinoma and a range of proliferative lymphoid conditions. In situ hybridisation (ISH) looking for virus-encoded RNA (EBER) transcripts...